South Rampart Pharma, Inc.

New Orleans, LA

UEI
MCE7AYNCB768
CAGE
8FZY8
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
478 Broadway St, New Orleans, LA 70118, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel non-narcotic analgesic for acute and chronic pain SB1NS119103 National Institute of Neurological Disorders and Stroke (NIH) $399,539
Novel non-narcotic analgesic for acute and chronic pain R42NS119103 National Institute of Neurological Disorders and Stroke (NIH) $5,294,687

Quick answers

Is South Rampart Pharma, Inc. registered in SAM.gov?

Yes. South Rampart Pharma, Inc.'s SAM.gov registration is active through February 3, 2027.

What is South Rampart Pharma, Inc.'s most recent federal award?

South Rampart Pharma, Inc.'s most recent federal grant award is Novel non-narcotic analgesic for acute and chronic pain (SB1NS119103), from National Institute of Neurological Disorders and Stroke (NIH), on September 30, 2020.

On GovTribe

See South Rampart Pharma, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login